GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alkermes Plc ALKS · USD

Health Care · US listing · 🇺🇸 United States

Compare

46.17

+0.59%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$1.56bn

FY2015FY2024

Net income

$367.1m

FY2015FY2024

Free cash flow

$405.6m

FY2015FY2024

Shareholders' equity

$1.46bn

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$1.56bn$1.66bn$1.11bn$1.17bn$1.04bn$1.17bn$1.09bn$903.4m$745.7m$628.3m
Gross profit$1.31bn$1.41bn$893.7m$976.4m$860.4m$990.6m$917.9m$748.6m$613.6m$489.3m
Research and development$239.6m$256.7m$381.8m$406.5m$394.6m$512.8m$425.4m$412.9m$387.1m$344.4m
Operating income$420.6m$420.0m−$142.3m−$29.3m−$112.4m−$162.1m−$99.1m−$147.9m−$208.7m−$224.3m
Net income$367.1m$356.0m−$158.3m−$48.2m−$110.9m−$196.6m−$139.3m−$157.9m−$208.4m−$227.2m
Diluted earnings per share2.162.09-0.97-0.30-0.70-1.25-0.90-1.02-1.38-1.52

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$2.06bn$2.14bn$1.96bn$2.02bn$1.95bn$1.81bn$1.82bn$1.80bn$1.73bn$1.86bn
Cash and short-term investments$751.7m$773.5m$608.5m$536.3m$635.0m$535.0m$539.3m$433.5m$497.2m$534.8m
Total liabilities$590.6m$933.5m$920.2m$911.9m$882.7m$720.0m$653.7m$594.4m$516.9m$541.5m
Debt—$290.7m$293.3m$295.8m$275.0m$277.1m$279.3m$281.4m$283.7m$349.9m
Shareholders' equity$1.46bn$1.20bn$1.04bn$1.11bn$1.07bn$1.09bn$1.17bn$1.20bn$1.21bn$1.31bn
Shares outstanding169m170m164m161m159m157m155m153m152m149m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations$439.1m$401.4m$21.0m$101.7m$82.8m$72.1m$99.3m$19.2m−$63.8m−$40.4m
Capital spending−$33.5m−$48.0m−$38.3m−$28.0m−$42.2m−$90.9m−$69.4m−$51.3m−$43.7m−$52.9m
Free cash flow$405.6m$353.3m−$17.3m$73.7m$40.6m−$18.8m$29.9m−$32.1m−$107.5m−$93.3m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue$394.2m$390.7m$306.5m$430.0m$378.1m$399.1m$350.4m$377.5m
Gross profit$342.6m$341.2m$257.3m$367.9m$315.0m$337.7m$291.7m$307.4m
Operating income$89.1m$93.0m$14.0m$163.0m$105.0m$110.0m$43.0m$178.6m
Net income$82.8m$87.1m$22.0m$147.0m$92.0m$91.0m$37.0m$112.8m
Diluted earnings per share0.490.520.130.880.560.550.230.66
Total assets$2.33bn$2.25bn$2.08bn$2.06bn$2.15bn$2.21bn$2.12bn$2.14bn
Cash and short-term investments$1.11bn$1.02bn$884.0m$751.7m$908.9m$876.1m$745.0m$773.5m
Debt————$286.0m$286.0m$287.0m$287.7m
Shareholders' equity$1.73bn$1.62bn$1.51bn$1.47bn$1.29bn$1.28bn$1.25bn$1.20bn

Financial ratios

Data as of 14 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin86.7%84.2%84.8%80.4%83.2%82.8%
Operating margin20.6%29.9%26.7%-1.6%8.4%-8.5%
Net margin16.4%23.6%21.4%-14.2%-4.1%-10.7%
Return on equity13.3%25.1%29.6%-15.2%-4.3%-10.4%
Return on assets9.6%17.9%16.7%-8.1%-2.4%-5.7%
Free cash flow yield8.4%7.1%6.6%0.9%2.0%2.0%
Revenue growth-5.2%-6.4%49.6%-5.3%13.0%-11.3%
Earnings growth-34.2%3.2%-324.8%228.6%-56.6%-43.6%
Current ratio3.55x3.04x2.86x2.27x2.25x2.53x
Debt to equity0.00x0.00x0.25x0.29x0.28x0.27x
Equity ratio71.9%71.3%56.3%53.1%55.0%54.7%
Interest coverage24.74x20.65x19.30x-1.39x8.82x-10.15x
R&D as a share of sales22.0%15.7%16.3%24.5%24.8%38.0%
Buybacks as a share of market value-1.3%2.1%-3.5%-1.5%-1.7%-0.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.9%5.9%9.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin84.5%83.4%83.5%82.5%
Operating margin26.1%12.1%5.1%-3.2%
Net margin22.4%9.4%2.7%-4.7%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings13.313.3-27.0-77.7-28.6-16.3-32.9-53.2-40.4-29.1
Price to sales3.12.83.83.23.02.74.29.311.310.5

Market value over time

30 Nov 2016 to 13 Oct 2026, in USD

$8.62bn$6.62bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-8%8%10%8%8%4%-30%-43%-8%36%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 15 May 2000

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.